Pyrazolo pyridine derivatives as NADPH oxidase inhibitors
US10772891B2 · kind B2 · utility
1Cited by
17References
27Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Apr 23, 2018 |
| Grant date | Sep 15, 2020 |
| Priority date | — |
| Expiry date | Apr 23, 2038 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY02A50/30
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention is related to pyrazolo pyridine derivatives of Formula (I), pharmaceutical composition thereof and to their use for the treatment and/or prophylaxis of disorders or conditions related to Nicotinamide adenine dinucleotide phosphate oxidase (NADPH Oxidase).
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.